Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Inventory (2016 - 2025)

International Stem Cell (ISCO) has disclosed Inventory for 16 consecutive years, with $1.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Inventory rose 14.96% to $1.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.6 million, a 14.96% increase, with the full-year FY2024 number at $1.1 million, down 9.03% from a year prior.
  • Inventory was $1.6 million for Q3 2025 at International Stem Cell, up from $1.5 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $1.6 million in Q3 2025 to a low of $1.1 million in Q1 2021.
  • A 5-year average of $1.3 million and a median of $1.3 million in 2023 define the central range for Inventory.
  • Peak YoY movement for Inventory: grew 29.12% in 2021, then dropped 9.03% in 2024.
  • International Stem Cell's Inventory stood at $1.2 million in 2021, then rose by 16.89% to $1.4 million in 2022, then decreased by 8.74% to $1.3 million in 2023, then fell by 9.03% to $1.1 million in 2024, then skyrocketed by 38.47% to $1.6 million in 2025.
  • Per Business Quant, the three most recent readings for ISCO's Inventory are $1.6 million (Q3 2025), $1.5 million (Q2 2025), and $1.3 million (Q1 2025).